In 2012, the World Health Organization projected depression to become the leading cause of the global burden of disease by 2030. Depression remains a major cause of disability worldwide.
Psychedelic therapy
Step into the future of mental healthcare.
Elevate your practice with an IPI Psychedelic Therapy Provider Certification. Deepen your clinical skills, expand your perspective, and learn in a community committed to meaningful change.

Rated by over 3,000 practitioners
Deepen your impact.
Expand what’s possible.
Becoming a psychedelic-assisted therapy provider allows you to transform lives right now with ketamine therapy while establishing yourself as an expert, as other medicines, such as MDMA and psilocybin, await future approvals. Deepen your impact with this cutting-edge modality that is transforming people’s lives.
Learn from more than 50 experts in psychedelic-assisted therapy and research, with an online format designed for a busy clinical practice.
For practitioners
ready to move care forward.
Designed for mental healthcare professionals who are ready to elevate their impact and help clients when current treatments have fallen short. Build an approach that puts you at the forefront of mental healthcare.
More tools for a growing
mental-health challenge.
Mental healthcare has advanced, yet too many people continue to struggle. The burden of depression, trauma, and other mental-health conditions calls for continued learning and new approaches.
A 2013 study reported that 90% of people experience trauma during their lifetime. Earlier U.S. estimates cited about 8 million people with PTSD in a given year; a Veterans Administration report estimated 22 veteran suicides per day. These figures underscore the longstanding burden of trauma.
Earlier U.S. estimates put annual mental illness at about one in five adults. For many, severe symptoms reduce quality of life and limit what they can do.
A history of collaboration.
Our work has included curriculum collaboration, training partnerships, and grant-supported provider education.

ASKP
ASKP board members participated in IPI training and provided feedback on the ketamine-assisted psychotherapy curriculum.

Usona Institute
Usona Institute researchers participated in IPI training and provided feedback on the psilocybin-assisted psychotherapy curriculum.

COMPASS Pathways
IPI was one of five U.S. organizations awarded a Compass Pathways grant in 2026 to develop provider training for post-approval COMP360 care. IPI independently directs its curriculum, faculty, and educational design.

Lykos Therapeutics
IPI served as a training partner for Lykos Therapeutics in MDMA-assisted therapy education, supporting the development of clinicians’ knowledge and therapeutic skills.
Rigorous learning.
Human connection.
Designed from the ground up to be taken online, so you can deepen your expertise without traveling or stepping away from your practice.
Comprehensive curriculum
A four-month, 140+ hour online curriculum led by more than 50 experts, covering protocols for investigational psychedelic-assisted treatments for PTSD, depression, anxiety, and more.
Advanced therapeutic skills
Go deeper into research, therapeutic process, preparation, dosing, integration, and clinic models. Explore how psychedelics work alongside other types of therapies.
A supportive learning community
Join a thriving network of peers, faculty, and teaching assistants, all dedicated to your success. Ask questions, share experiences, and receive ongoing support through the active community forum.
Recognized continuing education
Eligible participants may earn up to 49.0 continuing education credits across multiple healthcare professions. View the full accreditation details below.
IPI COMP360 Psilocybin Certification
If COMP360 is approved by the FDA, your enrollment includes this additional certification pathway, subject to applicable requirements.
“The IPI community is so accepting and they really work hard to create a space for us to make connections with each other and also with the leaders.”
A learning journey
built around your practice.
Combine self-paced Foundations study with a live cohort experience from February through May 2027. Build your skills across 140+ hours of learning, whether you’re entering psychedelic therapy or already practicing.
Foundations of Psychedelic Therapy
The asynchronous, self-study portion of the program lets you build your foundation at your own pace. You have up to two years to complete it.
Virtual Intensive I
The live portion of your training begins with the one-day Live Virtual Intensive, which consists of highly engaging talks by expert faculty. During this intensive, you will learn the fundamentals of psychedelic-assisted therapy while building community.
Virtual Intensive II
The live portion of your training wraps up with Live Virtual Intensive II, with advanced topics and innovative specialized methods to ensure participants are confident in their new knowledge and have the expertise to apply it correctly in their practices.
Your weekly rhythm
Learn, practice, and connect with your cohort throughout the four-month live portion of the program.
Weekly online lectures
Tuesdays · 9:00 AM Mountain TimeBuild your expertise through 60-minute lectures and panel discussions on psychedelic-assisted therapy.
Biweekly group seminars
Thursdays · 9:00–11:00 AM Mountain TimePractice and discuss psychedelic-assisted therapy techniques in 120-minute seminars with breakout groups.
Weekly home groups
60 minutes · Scheduling options available soonDiscuss cases and relevant clinical topics in small-group Zoom sessions.
Private community forum
Support throughout the live programConnect with peers, teaching assistants, and faculty for questions, discussion, and support through the private online portal.
The knowledge behind
confident, thoughtful care.
Six asynchronous modules connect ethics, cultural humility, research, preparation, therapeutic process, and integration. Begin before the live program and revisit the material at your own pace.
Module 1Professional development & ethics8 videosBuild a foundation for ethical, boundaried practice and therapist self-regulation.Ethics in psychedelic-assisted therapy · Integrating ketamine-assisted therapy into clinical practice · Professional liability · Protecting boundaries in psychedelic sessions
Psychedelics, Culture, and Consciousness Evolution
Michael Pollan
Therapeutic Competencies in Psychedelic Assisted Therapy
Sara Gael Beauregard, MA, LPC
Psychedelic Ethics
Shannon Carlin, MA, LMFT
Ethics in Psychedelic Therapy: A Roundtable Discussion
Sara Gael Beauregard, MA, LPC · Kylea Taylor, MS, LMFT · Devon Christie, MD · Shannon
Introduction to Therapist Self-Regulation
Joseph McCowan, PsyD
Relational Issues in Psychedelic Psychotherapy
Ian Wickramasekera, PsyD
Spiritual Emergence and Spiritual Emergency
Katrina Michelle, PhD, LCSW
Psychedelic Peer Support: Theory, Principles, and Practice
Sara Gael Beauregard, MA, LPC
Module 2Cultural humility & Indigenous use7 videosExplore Indigenous traditions, culturally attuned care, and equitable access to psychedelic healing.Indigenous history of psychedelic use · Diversity, equity, and inclusion · Confronting bias and cultural appropriation · The intersection of capitalism and psychedelics
Introduction to Curanderismo
Sofia Chavez, DNM
Psilocybin: A Mazatec Perspective
Yaqui A. Martínez-Robles, PhD, PsyD
Indigenous Uses of Psilocybin Mushrooms and Psychedelic Capitalism
Nicholas Spiers
Unpacking Spiritual Bypassing and Cultural Appropriation
Alejandro Castro, MA, LPC, LAC
Culturally Attuned Care in Psychedelic Assisted Therapy
Joseph McCowan, PsyD
Sacred Ceremony and Psychedelic-Assisted Therapy
Joe Tafur, MD
Protecting and Expanding Legal Access to Psychedelic Healing
Tasia Poinsatte
Module 3Research & pharmacology20 videosConnect the evidence, pharmacology, and clinical considerations across psychedelic medicines.History and current research in MDMA, psilocybin, ketamine, and other psychedelics · Chemistry and pharmacology · Patient education on benefits and challenges · Psychological safety
Scope of the TRD Problem: Limitations of the Conventional Psychopharmacology Model
Charles Raison, MD
Classic Psychedelics: What Are They, How Do They Work?
Robin Carhart-Harris, PhD
Psychedelic Research: History and Political Landscape
Torsten Passie, MD, MA
Introduction to Ketamine
Megan Oxley, MD · Sandhya Prashad, MD
Ketamine Neuropsychopharmacology
Kelsey Loupy, PhD
Efficacy and Safety of Ketamine in the Management of Anxiety and Anxiety Spectrum Disorders
Michael Banov, MD
Evidence Base for Racemic IV Ketamine for Treatment-Resistant Depression, Bipolar Depression, and Suicidal Ideation
Michael Banov, MD
Opiate Addiction
Randall Malchow, MD
Psilocybin-Assisted Therapy and Traumatic Memories
Frederick Barrett, PhD
Psilocybin: Unmet Needs, Pharmacology, Clinical Evidence, Mechanisms of Action and Development Challenges
Charles Raison, MD
Psilocybin: Existential Distress
Anthony P. Bossis, PhD
Psychedelic Research and Substance Use Disorders
Christopher Stauffer, MD
Psilocybin-Assisted Therapy: Alcohol Addiction
Kelley O’Donnell, MD, PhD
MDMA, Ketamine, and Psilocybin Pharmacology: Practical Considerations
Randy Buzan, MD
Medication-Assisted Psychotherapy with MDMA
Scott Shannon, MD
Adverse Effects and Drug Interactions of Psychedelics
Ben Malcolm, PharmD, MPH
Environmental Distress, Grief, and Psychedelics
Andrew Bryant, MPH, LICSW
Death and Dying
Rohini Kanniganti, MD
LSD and Mescaline
Ben Malcolm, PharmD, MPH
Microdosing
Ben Malcolm, PharmD, MPH
Module 4Preparation: screening, safety & informed consent15 videosPrepare for the therapeutic relationship, patient selection, informed consent, and the conditions that support care.Screening and monitoring · Mindfulness and intention setting · Physical preparation · Set and setting · Safety measures
Psychedelic Therapy Preparation Sessions
Sara Gael Beauregard, MA, LPC
Ketamine: Basics of Ketamine Consultation
Sandhya Prashad, MD
Ketamine: Simple Patient Selection Criteria—Mental Health Disorders
Erin Amato, MD
Ketamine: Complex Patient Selection Criteria—Dual Diagnosis, Axis II, Psychotic Disorders, Addictions, PTSD
Sandhya Prashad, MD
Ketamine Informed Consent
Megan Oxley, MD
Psilocybin Consultation: Screening, Intake, Assessment Protocols
Albert Garcia-Romeu, PhD
Basics of Suicide Risk Assessment
Coreen Herron, PMHNP
Psilocybin & the ACE Model for Depression
Rosalind Watts, PhD
Measurement Based Care
Saundra Jain, MA, PsyD, LPC
Agreements, Boundaries, and Safety Protocols
Sara Gael Beauregard, MA, LPC
Psilocybin-Assisted Therapy Set and Setting Roundtable
Drew Snyder, MS, LPC, NCC · Rebecca Ahnsdotter, CSWA · Yaqui A. Martínez-Robles, PhD, PsyD
Person-Centred Music for Psychedelic Therapy
Mendel Kaelen, PhD
Ethics of Touch in Psychedelic Work
Julane Andries, LMFT · Will Van Derveer, MD
Colorado Psilocybin Group Facilitation: Part 1
Jeanine Souren, MS
Colorado Psilocybin Group Facilitation: Part 2
Jeanine Souren, MS
Module 5Therapeutic process11 videosDevelop the relational and trauma-informed skills used to support psychedelic sessions.Inner Healing Intelligence · Non-ordinary states of consciousness · Safe uses of therapeutic touch · Trauma neuroscience, parts work, and grief
MDMA, Ketamine, and Psilocybin Therapy: Dose Administration Sessions
Sara Gael Beauregard, MA, LPC
The Art of Space Holding in MDMA Sessions
Sara Gael Beauregard, MA, LPC
Multiplicity and Parts in MDMA, Ketamine, and Psilocybin Sessions
Sara Gael Beauregard, MA, LPC
Psychedelic Dosing Session: Safety and Navigating Challenges
Sara Gael Beauregard, MA, LPC
Transference and Countertransference in MDMA, Ketamine, and Psilocybin Therapy
Brooke Balliett, LMFT
Introduction to Neuroscience of Trauma
Arielle Schwartz, PhD
Applied Trauma Neuroscience: Basic Skills
Arielle Schwartz, PhD
Mystical Experiences
William Richards, PhD
Psilocybin: Cases of Transpersonal Experiences
David B. Yaden, PhD
Psychedelic-Assisted Therapy and Grief
Anthony P. Bossis, PhD
Colorado Psilocybin Group Facilitation: Part 3
Jeanine Souren, MS
Module 6Integration tools5 videosHelp clients connect experiences with their values, daily lives, and ongoing care.An expanded spectrum of root causes · Mind-body practices · Somatic therapy and parts work · Values-based behavior change
Psychedelic Integration
Emily McKay, MA, LPC
Ketamine Integration Sessions
Veronika Gold, MA, LMFT
Colorado Psilocybin Group Facilitation: Part 4
Jeanine Souren, MS
Values-Driven Behavioral Approaches to Integration and Life Design
Keith Kurlander, MA, LPC
Integration with Lifestyle Medicine
Will Van Derveer, MD
See the work.
Build the practice.
Go beyond the core curriculum with session recordings and practical business training.

Psychedelic therapy
session recordings
Gain behind-the-scenes access to 40 hours of real psychedelic therapy sessions, showcasing medical consults, preparation, dosing, and integration in both ketamine- and psilocybin-assisted therapy. These recorded sessions offer a rare, immersive look at therapeutic techniques, clinical decision-making, and client-centered care in action.

Psychedelic Therapy
B-School
Step confidently into practicing psychedelic therapy with our 20-hour Psychedelic Therapy B-School—a business school for mental health providers ready to ethically integrate psychedelic therapy into their practice. Learn how to navigate operations, marketing, advertising and more with practical tools and ready-to-use forms. From running ads in google to scaling your offerings, this program gives you the foundation to grow with integrity and impact.
An investment in
your next chapter.
Four months of learning, a supportive clinical community, and practical tools for the evolving field of psychedelic therapy.
Explore eligibility and speak with admissions about your next steps.
Regular Tuition$8,000
Additional discounts and payment plans may be available on your admissions call.
Learn from top-tier experts.
You will be supported throughout your studies by a faculty of world-renowned leaders in psychedelic-assisted therapy and research. The faculty at the Integrative Psychiatry Institute is composed of the top-tier experts in their respective fields, teaching you the research, science and clinical skill sets needed for the use of ketamine, MDMA and psilocybin therapies. Lecturers vary by cohort.

Robin Carhart-Harris, PhD
Psychedelic science & brain imagingProfessional background
Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol, focused on the serotonin system, and an MA in Psychoanalysis from Brunel University, 2005. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression, a double-blind randomized controlled trial comparing psilocybin with the SSRI, escitalopram, for depression, published in the New England Journal of Medicine, and a multimodal imaging study in first time users of psilocybin. Robin has published over 100 scientific papers. He founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind. In 2021, he was listed in TIME magazine’s ‘100 Next’, a list of 100 rising stars shaping the future. Also in 2021, he moved to University of California, San Francisco, becoming the Ralph Metzner Distinguished Professor in Neurology and Psychiatry. At UCSF, Robin will serve as Director of the new Psychedelics Division within the translational neuroscience Centre, Neuroscape.

Rick Doblin, PhD
MDMA research & psychedelic policyProfessional background
Rick Doblin, PhD, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife, dog, and empty rooms from three children, one of whom is in college and two have graduated.

Michael Pollan
Culture & consciousnessProfessional background
For more than thirty years, Michael Pollan has been writing books and articles about the places where the human and natural worlds intersect: on our plates, in our farms and gardens, and in our minds. Pollan is the author of eight books, six of which have been New York Times bestsellers; three of them (including his latest, How to Change Your Mind) were immediate #1 New York Times bestsellers. Previous books include Cooked (2013), Food Rules (2009), In Defense of Food: An Eater’s Manifesto (2008) and The Omnivore’s Dilemma: A Natural History of Four Meals (2006), which was named one of the ten best books of 2006 by both the New York Times and the Washington Post. It also won the California Book Award, the Northern California Book Award, the James Beard Award for best food writing, and was a finalist for the National Book Critics Circle Award. A revised, young readers’ edition of Omnivore’s Dilemma was published in 2015. Pollan’s 2001 book, The Botany of Desire: A Plant’s-Eye View of the World, also a New York Times bestseller was recognized as a best book of the year by the American Booksellers Association and Amazon.com. Pollan is also the author of A Place of My Own (1997) and Second Nature (1991). An expanded edition of Food Rules, with original illustrations by Maira Kalman, was published in 2011. How to Change Your Mind was named one of the New York Times’ 10 Best Books of 2018. In 2020 he published a new audio book titled Caffeine, available from Audible. In 2021, he will publish a book titled This is Your Mind on Plants.
A four-hour Netflix miniseries based on Cooked premiered in February 2016. PBS presented a two-hour special documentary based on The Botany of Desire in fall 2009 and a two-hour documentary based on In Defense of Food was broadcast nationally in December 2015 and was nominated for an Emmy. Pollan also appeared in the Oscar-nominated 2008 documentary Food Inc., which was partly based on The Omnivore’s Dilemma. He is currently working on a four-part Netflix series based on How To Change Your Mind as well as a sequel to Food Inc.

Mary Sanders, LCSW
Trauma-informed & embodied careProfessional background
Mary is a Licensed Clinical Social Worker whose focus is on addressing trauma in communities of color and marginalized populations. She has worked with Black, Indigenous, (BIPOC), Veterans, immigrants and refugees from Iraq and Syria, foster youth, and LGBTQIA+ community members.
Mary currently provides community mental health services for formerly unhoused Veterans for Veteran Affairs in San Francisco, CA. In addition to her role working with Veterans, she has a private practice called EMPATH Center in Oakland, CA serving Black Indigenous People of Color (BIPOC). Her vision is to implement psychedelic-assisted psychotherapy and incorporate community integration in her private practice.
Mary is a trained psychedelic-assisted therapist from CIIS and MAPS, certified in Trauma - Focused Cognitive Behavioral Therapy, and is a somatic experiencing psychotherapist in-training. Mary is a founding board member at People of Color Psychedelic Collective.

Rosalind Watts, PhD
Psilocybin & the ACE modelProfessional background
Dr Rosalind Watts is a clinical psychologist and the founder of ACER Integration. She has been named as one of the 50 Most Influential People in Psychedelics as well as one of the top Top 16 Women Shaping the Future of Psychedelics.
As the former clinical lead on the Psilocybin for Depression trial at Imperial College London, Dr Watts developed the ACE model of psychedelic assisted therapy ‘Accept, Connect, Embody’ and led a clinical team guiding 60 people through that process. Her qualitative research with trial participants led to the development of the Watts Connectedness Scale, a psychometric tool for measuring outcomes of psychedelic therapy.
Through all her work, Rosalind's main learning has been that safe and effective use of psychedelics requires substantial integration support. She co-founded the UK's first psychedelic integration group, and has now launched a global online integration community, ‘Accept, Connect, Embody, Restore’ (ACER) where members follow a 12 month process together. Her websites are acerintegration.com and drrosalindwatts.com.

Joe Tafur, MD
Sacred ceremony & Indigenous medicineProfessional background
Joe Tafur, M.D., is a Colombian-American family physician originally from Phoenix, Arizona. After completing his family medicine training at UCLA, Dr. Tafur spent two years in academic research at the UCSD Department of Psychiatry in a lab focused on mind-body medicine. After his research fellowship, over a period of six years, he lived and worked in the Peruvian Amazon at the traditional healing center Nihue Rao Centro Espiritual. There he worked closely with master Shipibo healer Ricardo Amaringo and trained in ayahuasca curanderismo. In his book "The Fellowship of the River: A Medical Doctor's Exploration into Traditional Amazonian Plant Medicine," through a series of stories, Dr. Tafur shares his unique experience and integrative medical theories. He is currently a fellow at the University of Arizona’s Center for Integrative Medicine. To learn more about his work you can also visit drjoetafur.com.
With his multicultural community in Phoenix, Dr. Tafur co-founded the Church of the Eagle and the Condor (CEC) (learn more at churchofeagleandcondor.org). This spiritual community is dedicated to promoting the spiritual unity of all people through the practice of traditional Indigenous spirituality and sacred ceremonies. The CEC is currently pursuing legal protection for their practice of sacred Ayahuasca ceremony. Dr. Tafur is also a co-founder of Modern Spirit, a nonprofit dedicated to demonstrating the value of spiritual healing in modern healthcare. Among their projects is the Modern Spirit Epigenetics Project, an epigenetic analysis of the impact of MAPS MDMA-assisted psychotherapy. Their first results have now been submitted for publication. Learn more at modernspirit.org.

Anthony P. Bossis, PhD
Existential distress & griefProfessional background
Anthony P. Bossis, Ph.D. is a clinical psychologist and clinical assistant professor of psychiatry at NYU Grossman School of Medicine and NYU Center for Psychedelic Medicine conducting FDA-approved clinical research with the psychedelic compound psilocybin since 2009. Dr. Bossis was director of palliative care research and co-principal investigator on the 2016 clinical trial demonstrating a significant reduction in emotional distress from a single psilocybin session in persons with cancer, specifically, a rapid decrease in depression, anxiety, hopelessness, and demoralization along with improvements in spiritual well-being and quality of life.
Dr. Bossis is study director and lead session guide on an FDA-approved clinical trial evaluating psilocybin-generated mystical experience with religious leaders. His primary psychedelic research interests include the treatment of end-of-life existential distress and the study of consciousness, meaning, and spirituality. He is a training supervisor of psychotherapy at NYU-Bellevue Hospital Center and co-founder and former co-director of the Bellevue Hospital Palliative Care Service. He is on the faculty at the Center for Psychedelic Therapies and Research / California Institute of Integral Studies and the Art of Dying Institute in NYC.
Dr. Bossis is guest editor (with Charles Grob, M.D.) on the Special Series on Psychedelics for the Journal of Humanistic Psychology and has authored numerous publications on psychedelics, mystical experience, and end-of-life existential distress. He has a long-standing interest in comparative religion and mysticism and on the interface of psychology and spirituality. He maintains a private psychotherapy and consulting practice in NYC.

William Richards, PhD
Mystical experiencesProfessional background
William (Bill) is Director of Therapy at Sunstone Therapies, based at the Aquilino Cancer Center in Rockville MD. He also is a psychologist in the Center for Psychedelic and Consciousness Research in Baltimore where he has been implementing research studies with psilocybin at the Johns Hopkins School of Medicine since 1999, and teaches at the California Institute of Integral Studies. His graduate degrees include M.Div. (Yale), S.T.M. in the psychology of religion (Andover-Newton) and Ph.D. (Catholic University). He studied with Abraham Maslow at Brandeis University and with Hanscarl Leuner at Georg-August University in Göttingen, Germany, where his involvement with psychedelic research originated in 1963. From 1967 to 1977, he implemented projects of psychotherapy research with LSD, DPT, MDA and psilocybin at the Maryland Psychiatric Research Center, including protocols designed to investigate the promise of psychedelics in the treatment of alcoholism, depression, narcotic addiction and the psychological distress associated with terminal cancer, and also their use in the training of religious and mental-health professionals. His recent research at Johns Hopkins has focused on the potential value of psilocybin in the continuing education of professional religious leaders from different world religions. His book, Sacred Knowledge: Psychedelics and Religious Experiences, published by Columbia University Press, now has been translated into multiple languages.
Explore the full faculty

Rohini Kanniganti, MD
Death, dying & palliative careProfessional background
Physician Team Lead.
Rohini Kanniganti, MD, MSPH, HMDC is a Boulder based Board Certified Family Physician. She has served in hospice and palliative care for over a decade, currently at the Mountain Valley Hospice and Palliative Care in NC. She completed a fellowship in Integrative Psychiatry through the Integrative Psychiatry Institute, and serves at the Integrative Psychiatry Centers, as well as leading Physician support for the Experiential aspect of the IPI Psychedelic Assisted Therapy Training. She is a hybrid of science, art and sacred, and is always ready to play.

Will Van Derveer, MD
Therapeutic touch & lifestyle integrationProfessional background
IPI Co-Founder · Medical Director.
Will Van Derveer, MD is Co-Founder of Integrative Psychiatry Institute and Integrative Psychiatry Centers. Dr. Van Derveer was co-investigator on a phase 2 MAPS study of Psychedelic-assisted psychotherapy for treatment-resistant PTSD, and co-authored the publication of this study in 2018. He has also provided Psychedelic-assisted psychotherapy in two MAPS training studies. An active provider of KAP at his clinic in Boulder, CO, he has been teaching others KAP therapy for several years. Dr. Van Derveer contributed a chapter on mescaline in the 2021 "Handbook of Medical Hallucinogens" (edited by Charles Grob and Jim Grigsby). He is co-host of the Higher Practice Podcast.
Dr. Van Derveer regards unresolved emotional trauma as the most significant under-recognized root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.
For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass.

Keith Kurlander, MA, LPC
Values & behavior changeProfessional background
IPI Co-Founder.
Keith Kurlander, MA, LPC is the Co-founder of the Integrative Psychiatry Institute (IPI) and the Integrative Psychiatry Centers (IPC) along with Will Van Derveer, MD. He brings a professional and personal passion toward the innovation and evolution of the field of psychiatry, psychedelic medicine and psychotherapy.
The Integrative Psychiatry Institute is an educational platform that is advancing the field of mental health care with provider training focused on integrative medicine, functional medicine, lifestyle medicine, and psychedelic-assisted therapy.
The Integrative Psychiatry Centers serve patients with integrative psychiatry services as well as psychedelic-assisted therapy currently in form of IV and IM KAP.
He graduated Naropa University in 2005 with a master’s degree in Transpersonal Counseling Psychology. As a Partner of Boulder Psychotherapy Services, he has practiced integrative psychotherapy for over a decade. After years of treating highly complex patients, as well as a personal journey of overcoming complex trauma and mood-related issues, he turned toward integrative psychiatric practices as a key component to achieving mental health and understanding the healing process.
In 2014 he founded Higher Practice, an online company with the mission to empower therapists to achieve their highest potential in private practice. Keith believes mental health professionals are catalysts for positive social change and, therefore, are key influencers in uplifting consciousness and alleviating unnecessary suffering. With this in mind, he designed Higher Practice to provide mental health professionals with innovative clinical trainings for continuing education, as well as the most comprehensive business course available for those pursuing private practice.
He also co-hosts The Higher Practice Podcast for Optimal Mental Health. This weekly podcast interviews experts in the fields of neuroscience, psychotherapy, psychedelic-assisted psychotherapy, developmental psychology, human behavior, psychiatry, clinical psychology, and nutrition. The Higher Practice Podcast is dedicated to bringing mental health clinicians the most current and innovative methods for transforming clients’ lives, as well as their own.

Jaime Davila, MA, LPC
Program leadership & clinical trainingProfessional background
Director of Psychedelic Trainings.
Jaime received his Master of Arts in Counseling from Regis University and is a Licensed Professional Counselor in the state of Colorado. Originally Born in Puerto Rico, and raised in a military family, Jaime has spent time in Europe, Central America, and many states in the US. He brings a unique blend of interpersonal, analytic and technical skills to his healing work and also provides services in Spanish. Jaime heavily leverages his life experiences when providing services and employs an integrative approach heavily rooted in existential and transpersonal theories. This approach allows him to guide clients through the difficulties of life which often cause us to question the purpose or meaning of such experiences. Jaime has been described as someone with a warm and calm demeanor whose presence alone has been known to be a comfort to those who share his company.

Sara Gael Beauregard, MA, LPC
Therapeutic process & peer supportProfessional background
Lead Facilitator.
Sara is a psychedelic therapist and educator with expertise in MDMA-Assisted Therapy, ketamine-assisted therapy, psychedelic risk reduction, and psychedelic professional development. She served as the Course Director for the IPI Psychedelic-Assisted Therapy Training from 2020-2022 and currently serves as Lead Facilitator for the training. Sara worked at the Multidisciplinary Association for Psychedelic Studies (MAPS) beginning in 2013 where she held multiple titles including Harm Reduction Officer and Director of Harm Reduction, overseeing the work of the Zendo Project. Since 2015, she has served as an Investigator for MAPS Public Benefit Corporation Phase 2 and Phase 3 clinical trials researching the safety and efficacy of MDMA-Assisted Therapy for PTSD and currently works as a MAPS Educator and Associate Supervisor. Over the past decade, she has helped to train thousands of individuals on the topics of psychedelic-assisted therapy, psychedelic peer support, and personal and professional development in the psychedelic field. Sara believes in the potential of psychedelics as catalysts for individual, community, and collective healing. She lives in Boulder, Colorado with her partner Ryan and their King Charles Cavalier Pupplemousse.

Melissa Lavasani, MPP
Psychedelic policyProfessional background
Melissa Lavasani is Founder and Chief Executive Officer of Washington, DC-based Psychedelic Medicine Coalition, a national association committed to advancing the science supporting psychedelic medicine, while creating and protecting access to these medicines through advocacy and education on a federal level. Melissa is also President of Psychedelic Medicine Advocacy and its Political Action Committee which is dedicated to ensuring all Americans are educated and empowered to elect lawmakers that support safe, equitable access to these life-changing treatments. Prior to that, Melissa proposed Initiative 81, the Entheogenic Plant and Fungus Policy Act of 2020, the largest ballot initiative win in Washington DC's history with 76% approval. Inspired by her own experience as a professional, working mother using psychedelic medicines to overcome severe postpartum depression when the healthcare system failed her, Melissa is one of the leading voices for policy, politics, and advocacy in the psychedelic space. She is also a Founding Board Member of the Psychedelics and Healing Initiative at the Global Wellness Institute, and on the Advisory Boards of Drugs over Dinner and Universal Ibogaine.
Melissa has a Bachelor’s degree in Economics from Macalester College, a Masters degree in Management from the University of Denver, and a Masters in Public Policy from George Mason University. Born in Washington, DC to Iranian immigrants, Melissa currently lives in Northeast DC with her husband Daniel, daughter Lola (9), son Ramsey (6), and their rescue pitbull, Gus.

Arielle Schwartz, PhD
Trauma neuroscienceProfessional background
Arielle Schwartz, PhD is a licensed clinical psychologist, EMDR Therapy consultant, and certified yoga instructor with a private practice in Boulder, Colorado. She earned her Doctorate in Clinical Psychology at Fielding Graduate University and holds a Master’s degree in Somatic Psychology from Naropa University. She is the author of two books The Complex PTSD Workbook: A Mind-Body Approach to Emotional Control and Becoming Whole (Althea Press, 2016) and EMDR Therapy and Somatic Psychology: Interventions to Enhance Embodiment in Trauma Treatment (W. W. Norton, 2018). She is international sought out teacher offering trainings on topics of EMDR Therapy, Somatic Psychology, and Complex PTSD. She is dedicated to offering informational mental health and wellness updates through her writing, public speaking, social media presence, and blog.

Megan Oxley, MD
Ketamine & informed consentProfessional background
Megan Oxley, MD is the founder and medical director of Michigan Progressive Health. A Board Certified Emergency Medicine physician, Dr. Oxley graduated from prestigious Wayne State University in 2009. She completed her residency training in Emergency Medicine in Detroit, serving the inner city. She spent a decade working in emergency departments in Michigan and Maryland and then transitioned to working with ketamine after helping a family member with treatment resistant depression. Dr. Oxley has been providing ketamine infusions for over four years. She is a founding board member of the American Society of Ketamine Physicians, Psychotherapists and Practitioners and is the current Vice President.

Nicholas Brüss, EdD, LMFT
Internal Family Systems & psychedelic therapyProfessional background
Dr. Nicholas Brüss is a leading psychedelic therapist, researcher, advocate, and educator, who is passionate about helping people heal, grow, and live meaningful lives. He is a therapist on the ground breaking FDA Phase III clinical trial of MDMA-assisted therapy for PTSD sponsored by Multidisciplinary Association for Psychedelic Studies (MAPS) and a clinical supervisor for MAPS Public Benefit Corp. Certified in both Internal Family Systems (IFS) therapy and ketamine-assisted psychotherapy, he provides ketamine-assisted IFS therapy in private practice in California, New York and Texas. Dr. Brüss is the co-founder and lead clinical trainer at the Psychedelic Coalition for Health and is the Director of Psychedelic Medicine Advocacy for TREAT California.

Charles Raison, MD
Evidence & clinical researchProfessional background
Charles Raison, MD, is the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, WI. Dr. Raison also serves as Director of Clinical and Translational Research for Usona Institute and as Director of Research on Spiritual Health for Emory Healthcare in Atlanta, GA. In addition, Dr. Raison has served as mental health expert for CNN.com for many years. Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training. More recently, Dr. Raison has taken a leadership role in the development of psychedelic medicines as potential treatments for major depression. The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association “in recognition of his contributions to our understanding of evolutionary biocultural origins of mental health and illness.” With Vladimir Maletic he is author of “The New Mind-Body Science of Depression” published by W.W. Norton in 2017. Dr. Raison serves on the Scientific Advisory Board for the American Foundation for Suicide Prevention.

Joseph McCowan, PsyD
Self-regulation & culturally attuned careProfessional background
Joseph McCowan, PsyD, is a licensed clinical psychologist and psychotherapist, currently working in Los Angeles as a co-therapist in the MAPS sponsored phase 3 clinical trials of MDMA-Assisted Psychotherapy for PTSD. He is an alumni of MAPS August 2019 MDMA Therapy Training for Communities of Color. Joseph is deeply passionate about furthering education and awareness of the healing benefits of psychedelics for communities of color and in working to improve mental health outcomes for historically underserved communities.

Devon Christie, MD
Ethics & therapeutic touchProfessional background
Devon Christie, MD, is a family physician and certified Functional Medicine provider with a focused practice in chronic pain management. Devon is also a Registered Therapeutic Counsellor and certified Relational Somatic Therapist, as well as a certified Mindfulness-Based Stress Reduction (MBSR) teacher and Kundalini Yoga teacher with over 20 years’ personal experience in cultivating mindfulness and yogic practices. Devon is also a trained MDMA therapist with the Multidisciplinary Association for Psychedelic Studies (MAPS) and has training and experience in Ketamine Assisted Psychotherapy. Devon is a teacher with the California Institute of Integral Studies (CIIS) Certificate in Psychedelic Therapy and Research Program. She is passionate about educating health care providers in integrative mind-body wellness approaches, and therapists in somatic trauma-informed skillsets and relational nuances, especially in the context of psychedelic-assisted therapy. Devon is devoted to helping people uncover the root causes that lead to illness, connect with the wisdom and innate healing intelligence of their body-mind, and become active participants in their own wellbeing.

Brooke Balliett, LMFT
Relational boundariesProfessional background
Brooke Balliett, LMFT, is a licensed marriage and family therapist in Los Angeles, CA. Brooke has a passion for treating psychological, spiritual, emotional and relationship challenges through the development of self-awareness, emotional intelligence and recognition of the healing power we each inherently hold inside of us. From a framework integrating trauma work, developmental and transpersonal psychology, Brooke provides a range of psychedelic-assisted psychotherapies including: MDMA-assisted psychotherapy for the treatment of PTSD in clinical trials as a therapist supervisor and training assistant; Psilocybin Therapy for Treatment Resistant Depression in clinical trials as a therapist; and Ketamine-Assisted Psychotherapy as a therapist and clinical director. After over a decade of clinical service provision and program development in publicly funded community mental health centers across central Los Angeles, she co-founded the California Center for Psychedelic Therapy in 2019 as her offering to those seeking health within a limited system of accessible, effective care and as a commitment to furthering access to cutting-edge psychedelic treatments to heal individuals and the communities surrounding them.

Torsten Passie, MD, MA
Research history & political contextProfessional background
Torsten Passie MD, MA is a professor of psychiatry and psychotherapy at Hannover Medical School and visiting scientist at the Goethe University Franfurt/Main (Germany). He studied philosophy, sociology (M.A.) at Leibniz-University Hannover and medicine at Hannover Medical School. His medical dissertation was on existential psychiatry. He worked at the Psychiatric University Clinic in Zürich (Switzerland) and with Professor Hanscarl Leuner (Göttingen), the leading European authority on hallucinogens. At Hannover Mefdical School he directed the Laboratory for Neurocognition and Consciousness and did extensive research on altered states of consciousness and their healing potential, including research with hallucinogenic drugs (cannabis, ketamin, nitrous oxide, LSD, MDMA, psilocybin). He is a recognized expert on the pharmacology and therapeutic use of psychedelics. His publications appeared in Journal of Psychopharmacology, Neuropsychobiology, Addiction, CNS Neuroscience and Therapeutics and others. Some of his books are The Pharmacology of LSD (2010), Healing with Entactogens (2012), The Science of Microdosing Psychedelics (2019) and The history of MDMA (2021).

Mendel Kaelen, PhD
Music in psychedelic therapyProfessional background
Mendel Kaelen is the founder and CEO of Wavepaths, a startup providing music both for and as psychedelic therapy. Prior to this, he worked as a PhD and postdoctoral neuroscientist at Imperial College London since 2012, where his research was the first to demonstrate music’s central role in psychedelic therapies. He is a thought leader on the therapeutic use of music and publishes and speaks frequently on this topic. He has been featured in Nature News, the San Francisco Chronicle, Vice Motherboard, Rolling Stone and TEDx. Mendel lives and works on planet Earth, and in his spare time likes to get into nature, and out of his mind with his musical instruments.

Nicholas Spiers
Indigenous use & psychedelic capitalismProfessional background
Nicholas Spiers is an anthropologist and documentary filmmaker. He co-founded Agua de Rayo, a non-profit civil organization based in Mexico’s Sierra Mazateca, which is invested in visual ethnography and community projects and which also has an interest in Mazatec psychoactive plant use. He has a Master’s degree in visual anthropology from the University of Barcelona and is interested in the sensory experience of audiovisual mediums. He has recently created an award-winning series about the psychoactive plant Salvia divinorum. He is Chacruna’s web video producer, whereby he creates content collating different perspectives and discussions from Chacruna conferences through compact and compelling video formats. He is also co-director with Bia Labate of the documentary web series The Peyote Files.

Kylea Taylor, MS, LMFT
Ethics & boundariesProfessional background
Kylea Taylor, M.S., LMFT is a licensed psychotherapist (CA MFC #34901) who has been thinking, writing, and teaching about ethics for almost three decades. She developed InnerEthics®, a self-reflective, selfcompassionate, approach to relational ethics which she is now teaching in psychedelic psychotherapy trainings. Kylea started studying with Stanislav Grof, M.D. and Christina Grof in 1984 and was certified by them as a Holotropic Breathwork® practitioner in 1990. She worked with Stanislav Grof as a Senior Trainer in the Grof Transpersonal Training throughout the 1990s and worked for nine years in a residential substance abuse recovery program where she managed a women’s program and facilitated Holotropic Breathwork®. She is the author of The Ethics of Caring: Finding Right Relationship with Clients, The Breathwork Experience, Considering Holotropic Breathwork®, and is the editor of Exploring Holotropic Breathwork®. InnerEthics.com

David B. Yaden, PhD
Transpersonal experiencesProfessional background
David B. Yaden, PhD, completed his doctorate at the University of Pennsylvania and is now an Assistant Professor at Johns Hopkins University School of Medicine. His research focus is on the psychology, neuroscience, and psychopharmacology of spiritual, self-transcendent, and other positively transformative experiences. Specifically, David is interested in understanding: how do brief experiences result in long-term changes to well-being? He is currently conducting studies to determine whether and how psychedelics increase well-being and treat mental disorders. He has authored over 60 peer-reviewed academic articles and 14 academic book chapters. His first authored book came out on September 1st, 2022––The Varieties of Spiritual Experiences: 21st Century Research and Perspectives––with Oxford University Press. His scientific and scholarly work has been covered by The New York Times, The Wall Street Journal, The Washington Post, New York Magazine, NPR, CNN, and BBC. Tomorrow, David will be installed as the Roland Griffiths Professor of Psychedelic Research at Johns Hopkins.

Kelley O’Donnell, MD, PhD
Psilocybin & alcohol addictionProfessional background
Dr. Kelley O’Donnell is a board-certified psychiatrist and an Assistant Professor of Psychiatry at the NYU Grossman School of Medicine, and the Director of Therapist Training at the NYU Langone Center for Psychedelic Medicine. After receiving her medical degree and a PhD in Neuroscience at UCLA, she completed a psychiatry residency on the research track at NYU, where she continued as faculty after graduation. She is a study psychiatrist and psychedelic therapist working with psilocybin, MDMA, and ketamine, and she is involved in various initiatives to advance psychedelic education among medical professionals and trainees. In addition to her work at NYU, she is on the faculty of the ketamine-assisted psychotherapy training program at the Polaris Insight Center, and she is an Assistant Trainer in the MDMA Therapist Training Program at MAPS-PBC. She also has a small private practice in New York City, specializing in integrative depth psychotherapy, ketamine-assisted psychotherapy, and psychedelic integration.

Katrina Michelle, PhD, LCSW
Spiritual emergence & emergencyProfessional background
Katrina Michelle, PhD, LCSW earned her Ph.D. in Psychology from The Institute of Transpersonal Psychology at Sofia University and her Master’s in Social Work from Stony Brook University. For her doctoral research she conducted a heuristic study on Exploring Resistance to Spiritual Emergence. Her Master’s research focused on spiritual development within higher education.
Katrina worked as the director of harm reduction for the Multidisciplinary Association for Psychedelic Studies (MAPS PBC) at the Zendo Project and served for three years as the executive director of The American Center for the Integration of Spiritually Transformative Experiences (ACISTE). Katrina has served as graduate faculty at New York University’s Department of Applied Psychology, Columbia University’s School of Social Work, Fordham University’s School of Social Services, and The Institute for the Development of Human Arts.
Katrina is a member of the Emergent Phenomenology Research Consortium (EPRC) and currently working with an international team on research to elucidate adverse psychedelic experiences in order to contribute to evidence-based and trauma-informed integration practices. She is also a founding member of the advisory board for The Fireside Project, a psychedelic peer-support line.
Katrina is the founder and director of The Curious Spirit, a New York-based psychotherapy and coaching practice. She is also creator and producer of When Lightning Strikes, a documentary in progress intended to demystify the awakening process and help create a cultural context for understanding mystical phenomena while normalizing the often challenging elements of this natural human experience.

Andrew Bryant, MPH, LICSW
Environmental distress & griefProfessional background
Andrew Bryant, MPH, LICSW is a clinical social worker, psychotherapist, and co-Director of North Seattle Therapy & Counseling, with a clinical focus on the impact of climate change and ecological crisis on mental health. He also provides Ketamine-Assisted Therapy (KAT), in collaboration with Telos Transformational Therapies, and organizes a local psychedelic integration circle for therapists and healers. Andrew is the founder of Climate & Mind, a project dedicated to gathering and promoting resources related to climate psychology for clinicians, the media, and the public. As part of this project, he provides lectures, seminars and study groups on climate mental health, and has been interviewed and featured in a number of media stories on climate psychology, including The LA Times, The Washington Post, The Guardian, The New York Times, and other media outlets. He is a member of the Alliance of Climate Therapists-Northwest (ACT-NOW), and of the Climate Psychology Alliance-North America.

Tim Spalla, MA, LPC
Trauma & clinical mentorshipProfessional background
Licensed Professional Counselor | Founder, Agile Wellness Group | Co-Founder, The Wounded Healer Project
Tim Spalla is a Licensed Professional Counselor and doctoral student in Clinical Psychology at the University of Denver. He is the founder of Agile Wellness Group, a Denver-based private practice, and co-founder of The Wounded Healer Project, a nonprofit that provides pro bono, veteran-led mental health services to justice-involved veterans.
Before entering the mental health field, Tim spent nearly 20 years overseas, first as a U.S. Army Ranger Intelligence Specialist with multiple combat deployments to Iraq, then as a private intelligence contractor supporting U.S. Special Operations missions across the Middle East and Horn of Africa. In 2015, he partnered with the National Geographic Society as a wildlife crime investigator, working alongside African governments and conservation groups to combat international trafficking syndicates.
Following a decade-long personal battle with PTSD, addiction, and moral injury, Tim experienced a transformative healing crisis that redirected his path toward clinical work in 2019. He holds a master’s degree in Clinical Mental Health Counseling from Regis University, where he completed a yearlong internship with the Colorado Department of Corrections.
Tim specializes in trauma and moral injury recovery, with a focus on military veterans and first responders. His work integrates evidence-based clinical practices with psychospiritual approaches, including psychedelic-assisted therapies and Native American healing ceremonies. He is a 2022 Pat Tillman Scholar, recognized for his advocacy and research on innovative treatments for moral injury.

Sara Lewis, PhD, LCSW
Set, setting & mindfulnessProfessional background
Dr. Sara Lewis is Co-founder of Memoru Center for Visionary Healing Arts, and formerly Associate Professor and Director of Training and Research at Naropa University's Center for Psychedelic Studies. Her book Spacious Minds: Trauma and Resilience in Tibetan Buddhism (Cornell Univ. Press, 2019) investigates how Buddhist concepts of mind shape traumatic memory and pathways to resilience. Sara has also published research on ayahuasca and spiritual emergencies. She is a Lykos Therapeutics Associate Consultant and provides ketamine-assisted psychotherapy in Boulder, CO.

Emily McKay, MA, LPC
Trauma, somatics & integrationProfessional background
Lecturer · Home Group Facilitator.
Emily earned her Master’s degree in Contemplative Psychotherapy and Buddhist Psychology from Naropa University and holds certifications in Psychedelic-Assisted Therapy and Hakomi Mindful Somatic Therapy. Emily is also a licensed Natural Medicine Clinical Facilitator and Distinguished Educator in the state of Colorado. Her work integrates mindfulness, somatic awareness, and psychedelic therapies, grounded in the belief that every person has an innate capacity for healing and growth. In addition to her clinical practice, Emily serves as faculty with the Integrative Psychiatry Institute, where she trains mental health professionals in Ketamine and Psilocybin-Assisted Psychotherapy.

Jeanine Souren, MS
Psilocybin & group facilitationProfessional background
Psychologist and sexologist.
Jeanine Souren is a psychologist and sexologist with a focus on couples and family therapy. Her career is dedicated to helping repair, heal, and strengthen relational brokenness and sexual challenges for couples and individuals. She believes that relationships are at the heart of human emotions, whether it's the relationship with oneself or with others. Guided by the belief that self-knowledge is the beginning of all wisdom, she focuses on connecting and listening to this inner guide.
Jeanine is also an IPI trained psychotherapist in psychedelic assisted psychotherapy and serves as an educator and lecturer to a global audience of mental health professionals.
In 2022, Jeanine co-founded the Experiential Training Institute (ETI) alongside Hans, a psychiatrist. The institute is dedicated to training mental health professionals in the responsible use of psychoactive compounds, including the legal use of psilocybin-containing truffles in the Netherlands. ETI offers multi-day retreats where professionals gain first-hand experience with psilocybin truffles, deepening their understanding and paving the way for future treatments and applications in the field. Additionally, the institute provides small group retreats for individuals who, after screening, seek to enhance their personal growth and development.
Experience & Qualifications ● Psychotherapist (BIG registered) ● Psychologist ● Couples & Family Therapist (NVRG registered) ● Sexologist (NVVS registered) ● Psychedelic Assisted Psychotherapist (IPI accredited) ● Lecturer PAPT (Integrative Psychiatry Institute and Experiential Training Institute)

Margaret Brako, MSW, LCSW
Ketamine preparation & deliveryProfessional background
Margaret provides Ketamine-Assisted Therapy and psychotherapy at Sage Integrative Health in Berkeley, CA. In 2021, she was part of the team that offered the clinic’s first Ketamine Assisted Therapy training. Her practice emphasizes trauma-informed, relational, and mindfulness-based approaches for healing.
For seven years, Margaret worked in community-based programs, helping unhoused and underserved populations manage depression, trauma, and psychosis.
Margaret is a first-generation American who grew up in Minnesota. She loves running, dancing tango, and listening to audiobooks.

Yaqui A. Martínez-Robles, PhD, PsyD
Indigenous perspectives & integrationProfessional background
Yaqui A. Martínez-Robles is a psychologist with Masters, PhD and PsyD in Psychotherapy. Training in Gestalt Therapy; Group Therapy, Music Therapy; Narrative and postmodern therapy. Certification in Transpersonal Psychology and Holotropic Breathwork (Grof Transpersonal Training); and as Psychedelic-Assisted Therapy Provider (Integrative Psychiatry Institute). He is the author of four books, and co-author of another two, focused on the existential perspective of psychology and therapy. He has participation with chapters in several books and articles in several journals. Yaqui founded the Circle of Studies in Existential Therapy, in Mexico City, in 2002; where a master’s degree in existential-phenomenological therapy and analysis is offered. He teaches and trains existential-phenomenological psychology and therapy in Mexico and different countries. He is Honorary President of the Latin American Association of Existential Psychotherapy (ALPE). He works in private practice as a Gestalt therapist and existential-phenomenological therapist in modalities one-on-one, couples and groups.

Gloria Herrera Prats
Experiential & group psychotherapyProfessional background
Gloria Herrera Prats is an economist and a psychotherapist. As the latter, she has training in Gestalt Therapy, group therapy, psycho-corporal therapy and is a specialist in addictions.
For more than 20 years, she has been engaged in psychotherapy and has taught Gestalt Therapy for over 15 years. In fact, over the last 5 years, she has been teaching a specialty she created, along with a colleague, on the addictive experience from Gestalt´s perspective. In the process of creating and teaching such a program, she discovered psychedelic assisted therapy, triggering her interest, openness and willingness to learn more about psychedelic assisted therapy and its potential to help, especially in difficult processes, such as depression, anxiety, PTSD, eating disorders… which are often related to substance abuse.
At the same time, along her therapeutic practice, she found more and more frequently the need to accompany people in integration of experiences´ processes with different psychedelics.
In 2020 she attended a one-year seminar for therapists on Therapeutic Integration of Experiences with Psychedelics.

Elizabeth Willis, RN, MS
Nursing & clinical mentorshipProfessional background
Home Group Facilitator.
Elizabeth Willis RN, MS, PMHNP(c) is a co-founder of the Organization for Psychedelic and Entheogenic Nurses (OPENurses) and has practiced as an emergency department registered nurse (ED RN) in critical care settings for a decade. Passionate about disaster response and humanitarian work, her nursing path has taken her as far as Bolivia, Ecuador, Cambodia, Laos, and Zimbabwe. She currently works as a front-line provider ED RN at the University of California, San Francisco (UCSF). A 2017 graduate of the second cohort of the California Institute of Integral Studies (CIIS) Certificate in Psychedelic Therapies and Research (CPTR) program, she next earned a Master of Science (MS) degree from UCSF’s Psychiatric Mental Health Nurse Practitioner (PMHNP) program.
Psychedelics, peer-support, harm reduction, and nursing are areas where she has received advanced training and cultivated deep experiences. In west Sonoma County, CA, Liz has volunteered or worked for organizations as diverse as the Humane Society, Planned Parenthood, Red Cross, and Sutter VNA Hospice. Since 2013, as a volunteer with the Multidisciplinary Association for Psychedelic Studies (MAPS) for ZENDO Project, she has participated in all roles including medical lead and supervisor, training others in psychedelic harm reduction and holding space safely at numerous events and festivals in the United States, Costa Rica, and South Africa. In 2021, she was honored to serve as a supervisor for the launch of the pioneering psychedelic peer-support line — Fireside Project.
Her own personal healing journey began in Peru working within Shipibo traditions and ultimately led her to Teotihuacán, where her path as a Moondancer and as a Pipe Carrier walking in the Nahuatl lineage was initiated. Liz is looking forward to her future role as a PMHNP where she will continue to fulfill her mission:
To honorably bring psychedelic medicines and plant entheogens to the western medical model by elevating the art, science, and spirituality of nursing in the fields of psychedelic-assisted therapies and research.

Nikki Zellner, LCSW, SAC
Home group mentorshipProfessional background
Home Group Facilitator.
Nikki is a Licensed Clinical Social Worker based in Milwaukee, Wisconsin. In addition to serving as a clinical facilitator in psychedelic research, she is an educator in psychedelic medicine, training clinical trial facilitators and providing education in ketamine-assisted psychotherapy. She has received specialized training through the California Institute of Integral Studies, Polaris Insight Center, Naropa University, and MAPS/Lykos. Nikki has extensive experience working with a variety of psychedelic compounds within clinical research settings and also works with ketamine in her private practice where she utilizes a relational and attachment focused approach incorporating somatic attunement and the nervous system.

Kosu Boudreau
Ketamine & home group mentorshipProfessional background
Home Group Facilitator.
Kosu Boudreau is a graduate from IPI’s Psychedelic-Assisted Therapy Cohort #1 and currently works as a ketamine assisted therapist in Toronto, Canada. She also completed the MAPS MDMA therapy training.
Kosu worked in healthcare as a psycho-spiritual therapist and clinical educator for over 15 years before entering private practice. She integrates somatic, experiential, psychodynamic and parts work in her therapy style. Her down-to-earth approach is engaging, authentic and trauma-informed.
A self-professed learning nerd, Kosu is currently studying somatic attachment therapy and psychedelic somatic integration.

Shannon Carlin, MA, LMFT
Psychedelic ethicsProfessional background
Shannon Carlin, MA, LMFT, is the Director and Head of Training and Supervision at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS PBC), a 501(c)(3) non-profit. As the Director of Training and Supervision, Shannon oversees the development and implementation of the programs that provide training and supervision to prepare mental health and medical professionals to deliver MDMA-assisted therapy in approved clinical settings. Shannon started working with MAPS PBC in 2011 before joining MAPS PBC in 2016. In her dedication to supporting people through growth and healing, Shannon has served as a co-therapist on MAPS PBC-sponsored Phase 2 trials researching MDMA-assisted therapy for anxiety associated with life-threatening illness and MDMA-assisted therapy for severe PTSD. Shannon’s direct clinical work continues to inform the development and implementation of the training programs she oversees. Shannon’s previous professional experience includes the development of community programs delivering resources, services, training, and support for healthy living, life skills, employment, and positive youth development. Her work has served adults with schizophrenia, bipolar, and substance use disorder, families and youth in a low-income residential setting, and high school students learning about moderation management of drug and alcohol use. In her lifelong commitment to address homelessness, Shannon volunteers with housing projects and shelters and completed a farm internship with the Homeless Garden Project. Shannon received her master’s degree in Integral Counseling Psychology from the California Institute of Integral Studies and a bachelor’s degree in Cultural Anthropology from the University of California, Santa Cruz. An adventurer at heart, Shannon can be found in nature, backpacking, running, and dancing. She celebrates and cultivates relationship and community and is passionate about life, love, and thriving.

Ian Wickramasekera, PsyD
Relational issues in psychotherapyProfessional background
Ian Wickramasekera, PsyD, a clinical psychologist and have been a teacher of transpersonal psychology for over 20 years. He taught counseling related courses at Naropa University since 2015 and previously taught at Saybrook University, the Adler School of Professional Psychology, and the University of Illinois Medical School. His interest in psychedelically assisted psychotherapy began when He met and spent time with Dr. Timothy Leary in 1986. He loves researching anything related to mind/body/spirit phenomena. He is most well-known for his work in hypnosis and empathy which has won a number of awards and Fellowship in the American Psychological Association. However, he also developed research and theory involving biofeedback, Dzogchen, empathy, meditation, near death experiences, psychophysiology, Shamanism, spirituality, and transpersonal experiences. Almost all of his 50 plus publications can be accessed here: (12) Ian Wickramasekera (researchgate.net)

Sandhya Prashad, MD
Ketamine consultation & patient selectionProfessional background
Sandhya Prashad, MD is a board certified psychiatrist specializing in interventional modalities for treatment resistant disorders with a particular interest and expertise in KAP. She completed both medical school and psychiatry residency at Baylor College of Medicine. She has been in private practice in the Houston area since 2011 and has been utilizing intravenous "ket" since 2016. She has personally administered over 5,000 treatments. She is the founder and medical director of Sandhya J. Prashad, MD, Houston TMS Therapeutics. Dr. Prashad is involved on an international level with furthering awareness and education regarding the safe and effective use of KAP. She is a founder, the former secretary and the current president of ASKP3. Dr. Prashad has been appointed as a clinical assistant professor at Baylor College of Medicine in the Menninger Department of Psychiatry and Behavioral Sciences where she assists in education of residents and medical students regarding the use of KAP and TMS in clinical practice. She continues to work to expand her practice to include evidence based interventional treatments as they become available, and has a particular interest in expanding access and affordability of these treatments.

Kelsey Loupy, PhD
Ketamine neuropsychopharmacologyProfessional background

Frederick Barrett, PhD
Psilocybin & traumatic memoriesProfessional background
Frederick Barrett is a cognitive neuroscientist with training in behavioral pharmacology, and the Associate Director of the Johns Hopkins Center for Psychedelic and Consciousness Research. Dr. Barrett has been conducting psychedelic research at Johns Hopkins University since 2013, and his research in healthy participants and in patients with mood and substance use disorders focuses on the psychological and neurological mechanisms underlying the enduring therapeutic and other effects of psychedelic drugs. In 2017, he received an NIH “R03” grant as Principal Investigator to investigate biological mechanisms of psilocybin effects, the first federally funded research since the 1970s administering a classic psychedelic to people with psychedelic effects as the primary focus. He has developed measures of subjective effects of psychedelic drugs, and has also published first-in-human studies characterizing the acute and enduring effects of psilocybin on the brain. He is currently leading clinical trials to investigate the use of psilocybin to treat patients with major depressive disorder and co-occurring alcohol use disorder, and he is leading a number of ongoing studies aimed at better understanding the psychological, biological, and neural mechanisms underlying therapeutic efficacy of psychedelic drugs.

Albert Garcia-Romeu, PhD
Psilocybin screening & assessmentProfessional background
Albert Garcia-Romeu (Roh-May-Oh), Ph.D. is an Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. His current research interests include clinical applications of psychedelics, real-world drug use patterns, diversity in science, and the role of spirituality in mental health. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research and the International Society for Research on Psychedelics.

Coreen Herron, PMHNP
Suicide risk assessmentProfessional background
Coreen Herron is a psychiatric mental health nurse practitioner (PMHNP) with a nursing background in end-of-life care. She attended the first cohort of IPI’s Psychedelic assisted therapy practitioner program and now provides ketamine psychotherapy in private practice. Coreen also loves teaching hot yoga, which she has been doing for 15 years and getting outside and being active with her family.

Saundra Jain, MA, PsyD, LPC
Measurement-based careProfessional background
Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate, School of Nursing, at The University of Texas at Austin, and a psychotherapist in private practice. Dr. Jain is a co-creator of the WILD 5 Wellness Program and co-author of a well received workbook written for those interested in improving their mental wellness - KickStart30: A Proven 30-Day Mental Wellness Program. She is co creator of the Psychedelics and Wellness Survey (PAWS) exploring the intersect between psychedelics and wellness. She serves as a member of the Psych Congress Steering Committee providing direction regarding educational gaps/needs for mental health practitioners, and Sana Symposium providing psychedelics education for mental health and addiction professionals.

Drew Snyder, MS, LPC, NCC
Set, setting & psilocybin facilitationProfessional background
Drew is a licensed psilocybin facilitator in the state of Oregon, where he specializes in psychedelic-assisted healing. He received comprehensive training in this field through the Integrative Psychiatry Institute (IPI) in collaboration with MAPS, as well as through Bodhi Academy. Drew is deeply interested in the therapeutic potential of non-ordinary states of consciousness to support healing from trauma, addiction, depression, and other forms of psychological distress.
Drawing from a foundation in existential, meaning-centered approaches, Drew supports individuals in holistic healing journeys that address not only symptoms but also deeper questions of purpose, identity, and connection.

Rebecca Ahnsdotter, CSWA
Set, setting & psilocybin facilitationProfessional background
Rebecca Ahnsdotter is a trauma-informed clinical social worker with a private practice in the heart of Oregon’s Willamette Valley. Rebecca specializes in anxiety, depression, addiction, trauma, and life transitions, and works primarily with women, the LGBTQI+ community, and individuals deconstructing religious trauma. She brings a compassionate, person-centered approach to her work, incorporating EMDR, IFS, ACT, and Ketamine-assisted therapy to support her clients' healing and growth. Rebecca received psychedelic-assisted therapy training through Integrative Psychiatry Institute and is one of Oregon’s first licensed psilocybin facilitators.
Prior to working as a clinical therapist, Rebecca founded and operated Evergreen, a national non-profit organization that offers counseling to financially distressed populations. In this position, she developed counseling and educational curriculum, and trained and mentored a team of counselors who provided services to over 100,000 students in ten years. When not working with clients, Rebecca can be found exploring the beautiful Pacific Northwest with her partner and their six children.

Veronika Gold, MA, LMFT
Ketamine integrationProfessional background
Veronika Gold is a co-founder of Polaris Insight Center, and a psychotherapist licensed in California and Oregon. Veronika is a lead trainer at Polaris Insight Center Ketamine and Psychedelic Assisted Therapy training program, and she is a sub-investigator, supervisor, and a trainer in training for MAPS MDMA-AT program. Veronika has been a psychologist and psychotherapist specializing in trauma treatment, and in addition to psychedelic assisted therapy she has been a facilitator in EMDR and Organic Intelligence trainings.

Katy Barrs, PsyD
Military sexual traumaProfessional background
Dr. Katy Barrs completed her doctorate in clinical psychology at the University of Denver in 2007. She is currently an Associate Clinical Professor in the Military Psychology specialty at the Graduate School of Professional Psychology. After ten years of working for the Department of Veteran Affairs, she returned to the University of Denver to start and serve as the Clinic Director of the Sturm Center, a training clinic which serves Veterans, Servicemembers and their families. Dr. Barrs has worked with Veterans and Servicemembers at the Minneapolis V.A. Medical Center, the Boston V.A. Healthcare System, and the Denver Vet Center where she served in the role of Military Sexual Trauma Treatment Coordinator. Dr. Barrs oversees the Sturm Center, provides clinical education to multiple students within the clinic, and provides licensed community clinicians with education and consulting about these populations. She has been featured in the documentary Acronym, a timely expose about the nature of PTSD from combat. She recently completed Naropa University's Psychedelic Assisted Therapy Certification and is now enrolled in Elemental Psychedelics Mushroom Facilitator Advanced Pathway Program.

Michael Banov, MD
Ketamine evidence & clinical indicationsProfessional background
Michael D. Banov, MD is a triple board-certified Adult, Adolescent, and Addiction Psychiatrist and is the medical director of PsychAtlanta and PsychAtlanta Research Center in Atlanta, Georgia. PsychAtlanta is an outpatient behavioral health group practice providing comprehensive outpatient services to those suffering from a wide range of psychiatric problems.PsychAtlanta Research Center works with pharmaceutical companies to test new compounds for the treatment of psychiatric disorders including, but not limited to, depression, anxiety, bipolar disorder, attention deficit disorder, and schizophrenia.
Dr. Banov attended medical school at Emory School of Medicine and completed his psychiatry training at McLean-Mass General Hospital, Harvard Medical School residency program. He was chief resdient of the psychotic disorders program and was given a teaching faculty appointment at Harvard Medical School before moving back to Georgia. He is a certified clinical investigator, having received his certification from the Association of Clinical Research Professionals (ARCP). He is also board certfied as a Diplomate by the American Board of Integrative and Holistic Medicine. He is an assistant clincial professor of psychiatry at the Medical College of Georgia.
Dr. Banov has conducted over 100 clinical research studies with new and existing compounds in the management of acute and chronic psychiatric conditions. He runs a treatment resistant mood and anxiety program that includes ketamine, Spravato, and other innovative therapy options. He recently published a paper in CNS spectrums on ketamine in anxiety disorders and is a medical consultant for an Atlanta-based medical device company working on innovation solutions to deliver intransal medications in a controlled and safe manner.
See www.psychatlanta.com for more information about Dr. Banov

Randall Malchow, MD
Opioid addictionProfessional background
Randall Malchow, MD served as an anesthesiologist for 25 years in the armed forces before retiring as a colonel in 2008. He then became an associate professor at Vanderbilt University Medical Center in Nashville, where he was the first Vanderbilt physician to offer intensive ketamine infusion therapy in 2014. In 2015, he established one of the few ketamine infusion centers (KIC) in the Veteran Health Administration and the only KIC in the U.S. specifically targeting opioid cessation/reduction.
He has an extensive 30-year experience with the administration of ketamine for analgesic purposes and has presented his experience with ketamine in the veteran population at the American Society of Ketamine Physicians Annual Meeting in 2018. Dr. Malchow has published over 20 peer-reviewed journal articles and serves regularly on worldwide medical missions supporting those in need.
Dr. Malchow is honored to serve as the Medical Director for the AMG Ketamine & Wellness Center to provide compassionate and competent care for those suffering from chronic pain, opioid dependence, depression, PTSD, anxiety, and OCD.

Erin Amato, MD
Ketamine patient selectionProfessional background
Erin Amato, MD is a private practice Pediatric and Adult Psychiatrist at Montana Psychiatry & Brain Health Center in Billings, Montana. She was the first physician to bring Transcranial Magnetic Stimulation and Psychedelic treatment for depression to Montana and has focused her practice on innovative and integrative treatments to help patients find hope and healing. She completed TMS training at the Brain Stimulation Lab at MUSC and psychedelic assisted psychotherapy training through the Psychedelic Research and Training Institute (PRATI). In 2018, she founded The Center for Ideal Health with the aim to promote optimal health and aging through lifestyle and personalized medicine programs. She is currently anAdvanced Fellow in Anti-Aging, Metabolic and Functional Medicine with The American Academy of Anti-Aging Medicine and is passionate about helping people achieve optimal mood and memory across the lifespan through integrative and precision medicine.

Scott Shannon, MD
MDMA-assisted psychotherapyProfessional background
Scott has been a student of consciousness since his honors thesis on that topic at the University of Arizona in the 1970s under the tutelage of Dr. Andrew Weil. Following medical school, Scott studied Jungian therapy and acupuncture while working as a primary care physician in a rural area for four years. Psychedelic-assisted psychotherapy became a facet of his practice before this medicine was scheduled in 1985. He then completed a psychiatry residency at Columbia program in New York. Scott studied cross-cultural psychiatry and completed a child/adolescent psychiatry fellowship at the University of New Mexico.
In 2010 he founded Wholeness Center in Fort Collins. This innovative clinic provides cross-disciplinary evaluation and care for all mental health concerns. Scott serves as a site Principal Investigator and therapist for the Phase III trial of psychedelic-assisted psychotherapy for PTSD sponsored by (MAPS). He has also published numerous articles about his research on (CBD) in mental health. Currently, Scott works extensively with psychedelic-assisted-psychotherapy. He lectures all over the world to professional groups interested in a deeper look at mental health issues, safer tools, and a paradigm-shifting perspective about transformative care.
Different perspectives.
A stronger community.
At IPI we take the position that different perspectives and backgrounds are necessary for a vibrant community to thrive. In the field of psychedelic-assisted therapy, there are not enough providers who identify as members of groups who have been oppressed or marginalized. Particularly poignant is the reality that therapists who do not identify as members of the BIPOC and LGBTQIA+ communities struggle with providing care that is both culturally competent and sensitive to the unique challenges of oppression and marginalization. We are committed to a diverse faculty, equity among the learners and education that creates cultural competency.
“I was so taken back at how inclusive this program was. As a therapist of color, many trainings and programs include culture as part of the program. This program was different; it did not include culture, it made it the foundation of learning from every aspect. I felt seen, heard, and understood.”

Learning that stays
with you.
This program is worth the investment if you are interested in learning about psychedelic assisted therapy, where it is and where it’s going as well as your own personal growth. The presenters, faculty, and staff really provided a seamless experience that I would highly recommend.
The energy of the training experience is like no other professional training I’ve attended. The Immediate sense of community, openness, curiosity, and connection adds a depth to the information so it can be more fully integrated in both personal and professional spheres
I may be a therapist with lots of experience in my field but this program pulled me into areas of practice that have broadened my perceptions, increased my capacity for relating to clients in all settings and has trained me to be a really good psychedelic assisted therapist.
The program is highly organized, well developed, with a wide range of psychedelic assisted psychotherapy topics as well and inclusion and diversity education and awareness. The teachers had a palpable sense of integrity that, in my opinion, sets this program apart from the rest. Would highly recommend this program to others.
The program is highly comprehensive and well organized. I really liked the variety of perspectives that the presenters came from. The IPI staff did an amazing job organizing the event and managing any and all technical issues. I would highly recommend to anyone interested in learning more about psychedelics and psychedelic therapies and research.
The intensive was phenomenal. Even more than I expected. Impressive lecturers and participants. Well organized. Participants are genuine and eager to learn.
The presenters so far in this program have been phenomenal and engaging. The breadth of subjects in this psychedelic wellness field are highlighted very well. You can tell the organizers put a lot of care and thought into this program.
From the moment this training started, I found myself captivated by the instructors, course developers, leadership, and last but not the least, the fellow students. It is phenomenal to see so many disciplines come together to collaborate, learn, and lift one another up! I’ve already learned so much, and continue to be inspired.
The lectures were well-organized and provided a wide foundation for psychedelic practice. The emphasis on being an ethically grounded practitioner was especially welcomed.
The incorporation of wide range of topics beyond the psychedelics such as integrative health, artists, visionaries, harm-reduction, racism – everything is so welcome and needed. Thank you for the great variety which will inform my practice for years to come..
Hear about the experience.
Advance your skills.
Earn CE/CME credit.
Continuing education credit for this program is provided through AKH Inc., Advancing Knowledge in Healthcare. AKH Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Eligible participants may earn up to 49.0 continuing education credits, with accreditation available across multiple healthcare professions. Continuing education credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP), and social workers may earn continuing education credit through the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program.
guarantee
Our commitment to
furthering your education.
The knowledge, experience, and confidence you will gain from attending the IPI Psychedelic Therapy Provider Certification is unparalleled.
No other program provides a learning experience like this, from the quality of training to the world-class faculty ready for your every question.
The IPI Psychedelic Therapy Provider Certification will help you feel confident providing ketamine, but will also bring your knowledge base up to date on the latest evidence.
Make an investment in yourself and your education. Take your practice to a new level of patient care.
And if you’re not happy with the program, you can get a full refund within the first 14 days after the date that you pay and register, as long as it’s before the start of the program. Once the program starts, no refunds will be issued. Simply reach out to our team, let us know what we could have done better, and your refund will be on its way.

“This training has been well organized, professional and so very inspiring! It brings together all of the elements that are at times siloed in medicine, mental health and spirituality. Highly recommend!”
Make room for
what comes next.
Explore the format, support, and requirements of your certification.
When are the online lectures?
Online lectures run weekly during the live portion of the program, February–May 2027, on Tuesdays at 9:00 AM Mountain Time. If you cannot attend a session, you can watch the recording in your online library during your two-year access period.
What type of mentorship will I receive?
There will be time during the large group seminars for feedback from teaching assistants, as well as during the live experience if you attend. In addition, there is a time for Q+A during every live lecture, as well as a community forum. You will also be assigned to a small group mentorship video call that meets for an hour weekly, where you can review case studies and ask further questions.
How long can I access my course materials?
You receive two-year access to your online library of course materials and session recordings. Your Foundations self-study materials are available as soon as you register.
Will I be automatically certified at the completion of the program?
You will receive our IPI Psychedelic Therapy Provider Certification as long as you satisfactorily pass all quizzes, the Foundations of Psychedelic Therapy asynchronous and live learning final exams, and meet our attendance requirements.
Do I have to attend the two live intensives?
You are expected to attend both online conferences. We will also be doing group exercises and other community-building activities. However, please contact us with any extenuating circumstances.
When will I get access to the Foundations of Psychedelic Therapy asynchronous materials?
You get access as soon as you register. Foundations of Psychedelic Therapy is the asynchronous, self-study portion of the program, and you have up to two years to complete it.
What format are the recordings in?
Recordings are video, audio and transcripts. Generally, a slide deck is also used by the presenter.
What is COMP360, and what training is included?
COMP360 is Compass Pathways’ investigational synthetic psilocybin treatment being studied for treatment-resistant depression. It is not FDA-approved.
Your program includes the IPI COMP360 Psilocybin Certification pathway, subject to FDA approval and applicable requirements: Part A, Foundations of Psychological Support, includes 25 hours of self-paced study over approximately three weeks. Part B is a five-hour live online COMP360 Intensive, available post-approval, focused on treatment protocols, care-team roles, and applied case discussions.
Completing training alone does not authorize COMP360 delivery. Any required REMS certification and other applicable clinical, legal, and institutional requirements must also be met.
Take your practice to a new level of patient care.
Make an investment in yourself and your education.
February – May 2027
Regular Tuition$8,000
Additional discounts and payment plans may be available on your admissions call.
Still have more questions? Contact Us
Step 1 of 2
Do you already have one of the following credentials?
- Professional Clinical Counselor (LPC)
- Marriage and Family Therapist (LMFT)
- Clinical Psychologist (PhD/PsyD)
- Clinical Social Worker (LCSW)
- Pre-Licenced Therapist (MA)
- Chaplain (M.Div.)
- Physician (MD/DO)
- Physicians Assistant (PA)
- Nurse Practitioner (NP)





























































































































Nancy Goodman, MA, LCSW











































































































